Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 184

  • Showing results for vasopressin schizophrenia. Your search for vasopressin scizophrenia retrieved no results.
1.

Imaging neuropeptide effects on human brain function.

Lefevre A, Hurlemann R, Grinevich V.

Cell Tissue Res. 2018 Aug 1. doi: 10.1007/s00441-018-2899-6. [Epub ahead of print] Review.

PMID:
30069597
2.

Atrial natriuretic peptide and posterior pituitary neurohormone changes in patients with acute schizophrenia.

Guzel D, Yazici AB, Pek TM, Doganay S, Simsek ABS, Saglam K, Turan C, Yazici E.

Neuropsychiatr Dis Treat. 2018 Jul 16;14:1855-1860. doi: 10.2147/NDT.S169619. eCollection 2018.

3.

Neurobiology and consequences of social isolation stress in animal model-A comprehensive review.

Mumtaz F, Khan MI, Zubair M, Dehpour AR.

Biomed Pharmacother. 2018 Sep;105:1205-1222. doi: 10.1016/j.biopha.2018.05.086. Epub 2018 Jun 22. Review.

PMID:
30021357
4.

Selective and non-selective OT receptor agonists induce different locomotor behaviors in male rats via central OT receptors and peripheral V1a receptors.

Wolfe M, Wisniewska H, Tariga H, Ibanez G, Collins JC, Wisniewski K, Qi S, Srinivasan K, Hargrove D, Lindstrom BF.

Neuropeptides. 2018 Aug;70:64-75. doi: 10.1016/j.npep.2018.05.007. Epub 2018 May 21.

PMID:
29807652
5.

The hypothalamus and neuropsychiatric disorders: psychiatry meets microscopy.

Bernstein HG, Dobrowolny H, Bogerts B, Keilhoff G, Steiner J.

Cell Tissue Res. 2018 May 16. doi: 10.1007/s00441-018-2849-3. [Epub ahead of print] Review.

PMID:
29767278
6.

Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review.

Yuen JWY, Kim DD, Procyshyn RM, White RF, Honer WG, Barr AM.

Front Neurosci. 2018 Apr 4;12:203. doi: 10.3389/fnins.2018.00203. eCollection 2018.

7.

Associations of oxytocin and vasopressin plasma levels with neurocognitive, social cognitive and meta cognitive function in schizophrenia.

Aydın O, Lysaker PH, Balıkçı K, Ünal-Aydın P, Esen-Danacı A.

Psychiatry Res. 2018 Mar 23. pii: S0165-1781(17)31776-6. doi: 10.1016/j.psychres.2018.03.048. [Epub ahead of print]

PMID:
29609987
8.

The Role of Neurohypophyseal Hormones Vasopressin and Oxytocin in Neuropsychiatric Disorders.

Iovino M, Messana T, De Pergola G, Iovino E, Dicuonzo F, Guastamacchia E, Giagulli VA, Triggiani V.

Endocr Metab Immune Disord Drug Targets. 2018;18(4):341-347. doi: 10.2174/1871530318666180220104900.

PMID:
29468985
9.

Strain differences in the susceptibility to the gut-brain axis and neurobehavioural alterations induced by maternal immune activation in mice.

Morais LH, Felice D, Golubeva AV, Moloney G, Dinan TG, Cryan JF.

Behav Pharmacol. 2018 Apr;29(2 and 3 - Special Issue):181-198. doi: 10.1097/FBP.0000000000000374.

PMID:
29462110
10.

Chronic Intranasal Oxytocin has Dose-dependent Effects on Central Oxytocin and Vasopressin Systems in Prairie Voles (Microtus ochrogaster).

Guoynes CD, Simmons TC, Downing GM, Jacob S, Solomon M, Bales KL.

Neuroscience. 2018 Jan 15;369:292-302. doi: 10.1016/j.neuroscience.2017.11.037. Epub 2017 Nov 26.

PMID:
29183825
11.

Primary polydipsia in the medical and psychiatric patient: characteristics, complications and therapy.

Sailer C, Winzeler B, Christ-Crain M.

Swiss Med Wkly. 2017 Nov 1;147:w14514. doi: 10.4414/smw.2017.14514. eCollection 2017. Review.

12.

Up-regulated expression of oxytocin mRNA in peripheral blood lymphocytes from first-episode schizophrenia patients.

Yang X, Tang Y, Wei Q, Lang B, Tao H, Zhang X, Liu Y, Tang A.

Oncotarget. 2017 Aug 14;8(45):78882-78889. doi: 10.18632/oncotarget.20252. eCollection 2017 Oct 3.

13.

Unexpected hypotension in catecholamine reversal: a case report.

Okada Y, Ishi W, Narumiya H, Liduka R.

J Med Case Rep. 2017 Oct 6;11(1):285. doi: 10.1186/s13256-017-1442-9.

14.

Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia.

Rubin LH, Wehring HJ, Demyanovich H, Sue Carter C, Pournajafi-Nazarloo H, Feldman SM, Earl AK, August S, Gold JM, Kelly DL.

Schizophr Res. 2018 May;195:409-411. doi: 10.1016/j.schres.2017.09.041. Epub 2017 Sep 29. No abstract available.

PMID:
28965776
15.

Arginine vasopressin improves the memory deficits in Han Chinese patients with first-episode schizophrenia.

Geng CH, Wang C, Yang J, Wang H, Ma RQ, Liu X, Wang CH.

Peptides. 2017 Nov;97:8-15. doi: 10.1016/j.peptides.2017.09.002. Epub 2017 Sep 5.

PMID:
28882471
16.

Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems.

Stohn JP, Martinez ME, Zafer M, López-Espíndola D, Keyes LM, Hernandez A.

Genes Brain Behav. 2018 Jan;17(1):23-35. doi: 10.1111/gbb.12400. Epub 2017 Aug 4.

PMID:
28715127
17.

Radiosynthesis and evaluation of 1-substituted 3-(2,3-dihydro-1H-inden-2-yl)-6-(1-ethylpropyl)-(3R,6R)-2,5-piperazinedione derivatives as PET tracers for imaging the central oxytocinergic system.

Marzano C, Jakobsen S, Salinas C, Tang SP, Bender D, Passchier J, Plisson C.

J Labelled Comp Radiopharm. 2017 Oct;60(12):556-565. doi: 10.1002/jlcr.3535. Epub 2017 Sep 21.

PMID:
28670707
18.

Potent and selective oxytocin receptor agonists without disulfide bridges.

Adachi Y, Sakimura K, Shimizu Y, Nakayama M, Terao Y, Yano T, Asami T.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2331-2335. doi: 10.1016/j.bmcl.2017.04.030. Epub 2017 Apr 12.

PMID:
28438540
19.

A translational approach for NMDA receptor profiling as a vulnerability biomarker for depression and schizophrenia.

Gunduz-Bruce H, Kenney J, Changlani S, Peixoto A, Gueorguieva R, Leone C, Stachenfeld N.

Exp Physiol. 2017 May 1;102(5):587-597. doi: 10.1113/EP086212. Epub 2017 Apr 12.

PMID:
28294453
20.

Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders.

Szczepanska-Sadowska E, Zera T, Sosnowski P, Cudnoch-Jedrzejewska A, Puszko A, Misicka A.

Curr Drug Metab. 2017;18(4):306-345. doi: 10.2174/1389200218666170119145900. Review.

PMID:
28117000

Supplemental Content

Loading ...
Support Center